a) Johnson & Johnson
b) Pfizer
c) Moderna
d) None of these
The United States has recommended a pause in the administration of the single-dose Johnson & Johnson COVID-19 vaccine after reports of potentially dangerous blood clots post-vaccination.Â
a) Johnson & Johnson
b) Pfizer
c) Moderna
d) None of these
The United States has recommended a pause in the administration of the single-dose Johnson & Johnson COVID-19 vaccine after reports of potentially dangerous blood clots post-vaccination.Â